• Open Access
    Review

    Echocardiographic Management of papillary muscle rupture during acute myocardial infarction

    Paolo G. Pino 1*
    Iris Parrini 2
    Antonella Moreo 3
    Antonio Terranova 4
    Federico Nardi 5

    Explor Cardiol. 2025;3:101242 DOI: https://doi.org/10.37349/ec.2025.101242

    Received: October 23, 2024 Accepted: December 12, 2024 Published: January 10, 2025

    Academic Editor: Dmitry Duplyakov, Samara State Medical University, Russian Federation

    Abstract

    Papillary muscle rupture is a rare but fatal complication of acute myocardial infarction. The incidence of this complication has been reduced to less than 0.1% of patients due to the advent of primary percutaneous coronary intervention. Cardiogenic shock and acute pulmonary edema are the most common clinical presentations. In this review, we describe the role of transthoracic and transesophageal echocardiography in identifying the type, location, and hemodynamic consequences of the three different echocardiographic patterns of papillary muscle rupture. This information is crucial for managing medical therapy and determining the appropriate surgical or percutaneous treatment.

    Keywords

    Papillary muscle rupture, acute myocardial infarction, echocardiography, mitral regurgitation, therapy

    Introduction

    The most dramatic and fatal complication of acute myocardial infarction is the rupture or tearing of infarcted myocardial tissue. Although rare, these complications are associated with very high in-hospital mortality rates. Papillary muscle rupture (PMR), along with interventricular septum rupture and left ventricular free wall rupture, is one of these severe complications.

    The decline in the incidence of PMR in recent decades can be attributed to the widespread use of primary percutaneous coronary reperfusion interventions. The current incidence rate ranges from 0.05% to 0.26%, depending on diagnostic criteria, the quality of diagnostic techniques, and the echocardiographic patterns used to detect PMR.

    However, despite the reduced incidence, the in-hospital mortality rate (5%) remains high, particularly in patients managed conservatively (80%) and even in those undergoing surgery. Furthermore, in about half of the cases, the presence of hemodynamic instability, such as cardiogenic shock, often results in the decision to refrain from cardiac surgery during the acute phase due to the high surgical risk [14].

    PMR accounts for more than half of the cases of acute severe mitral regurgitation following myocardial infarction. The remaining cases are secondary to left ventricular dysfunction, which leads to leaflet displacement and tethering of leaflets.

    A recent Seminar, published by leaders in each field, provided an update on the acute mechanical complications of myocardial infarction, including right ventricular infarction, severe mitral regurgitation, ventricular septal rupture, and free wall rupture [5]. One section of this seminar focused specifically on the management of severe mitral regurgitation risk [6].

    Clinical presentation and pathophysiology

    PMR typically occurs within the first week after an acute ischemic event, most commonly between the 2nd and 6th day. It is more frequent in myocardial infarctions with ST-segment elevation and less frequent in non-ST-segment elevation infarctions.

    PMR is usually a complication of a first infarction, particularly in patients with delayed presentation or without revascularization, and accounts for 36.3% of in-hospital deaths associated with acute myocardial infarction [7].

    Patients with PMR are more likely to be older females with hypertension and chronic kidney disease, and less likely to have diabetes [6]. In patients with PMR, single-vessel occlusion is common, with occlusion of the right coronary artery (RCA) being more frequent than that of the left circumflex artery (LCX), and occlusion of the left anterior descending artery (LAD) being the least likely.

    Rupture of the posteromedial papillary muscle (PPM) is more frequent than rupture of the anterolateral papillary muscle (APM) due to its single-vessel perfusion from the dominant RCA or LCX. This occurs 3 to 12 times more often than rupture of the APM, which is protected by a dual blood supply from both the LAD and LCX, reducing the risk of single-vessel occlusion [811].

    Normal mitral valve closure depends on the correct apposition of both leaflets, whose symmetrical overlap ensures proper systolic coaptation. This mechanism, which prevents mitral regurgitation, is supported by the appropriate traction of the chordae tendineae and the papillary muscle complex. Both papillary muscles distribute the chordae tendineae to both the anterior and posterior leaflets. PMR significantly disrupts the mitral valve competency mechanism [7, 1215].

    PMR can be complete, involving rupture at the papillary trunk, or partial, when the lesion affects one or more heads of the papillary muscle, or rarely at the insertion of the chordae tendineae. Some authors define a rupture as “complete” when it involves the larger head of the papillary muscle. The severity of mitral regurgitation depends on the type of rupture and the group of chordae tendineae involved, considering that a single papillary muscle distributes chordae to both the anterior and posterior leaflets (Figure 1).

    Mitral valve leaflet involvement in relation to the different types of the PPM rupture. AML: anterior mitral leaflet; PML: posterior mitral leaflet; APM: anterolateral papillary muscle; PPM: posteromedial papillary muscle

    Partial rupture is the more common cause of varying degrees of mitral regurgitation, while complete rupture, which causes prolapse of both leaflets, leads to severe mitral regurgitation, often presenting clinically with pulmonary edema and cardiogenic shock [12, 14, 16, 17].

    Clinical suspicion for PMR should be high in patients with acute myocardial infarction who, within the first week (typically on the third or fourth day), experience a sudden worsening of symptoms, such as rapidly progressive pulmonary edema or cardiogenic shock with hypotension. In such cases, the presence of a midsystolic or holosystolic murmur on auscultation is not consistent due to the equalization of left atrial and left ventricular pressures, a phenomenon known as “silent” mitral regurgitation.

    Given the wide range of clinical presentations and the challenge in categorizing patients for optimal treatment selection, a clinical classification has been proposed to establish a common language within the Heart Team. The clinical presentation is divided into four types, ranging from type 1 (the most severe) to type 4 (the least severe). A type 1 patient presents with shock, pulmonary edema, or cardiac arrest. Type 2 includes patients with severe heart failure or pulmonary edema but with preserved perfusion pressure. Type 3 patients experience episodes of pulmonary congestion or flash pulmonary edema. The least severe, type 4, is characterized by moderate or mild heart failure [18].

    Acute mitral insufficiency due to PMR: echocardiographic diagnosis

    Echocardiography is the preferred diagnostic method for accurately diagnosing PMR. Transthoracic echocardiography (TTE) has been the first-line diagnostic tool for PMR since the 1980s [1921].

    With the introduction of transesophageal echocardiography (TEE), the diagnosis of PMR has become more precise. Although advancements in TTE probes now allow for good diagnostic images in most cases, TEE provides detailed anatomical information that can guide therapeutic decisions.

    The anatomy of PMR is complex and highly variable, depending on the extent of necrosis and the subsequent anatomical and functional changes, which influence the echocardiographic appearance.

    In 1996, Nanda’s group published an echocardiographic classification based on transesophageal evidence, correlating echocardiographic features with the main types of PMR [22].

    In clinical practice, and in our experience, this classification is both practical and valuable for diagnostic and prognostic purposes:

    • Partial-incomplete rupture. In partial-incomplete rupture, the partially ruptured papillary muscle remains adherent to the ventricular wall and exhibits chaotic movement.

    • Partial-complete rupture. In partial-complete rupture, the ruptured portion of the papillary muscle is freely mobile within the left ventricle but does not protrude into the left atrium during systole.

    • Subtotal/total (incomplete/complete) rupture. In subtotal or total rupture, the heads or the entire trunk of the papillary muscle protrudes into the left atrium during systole, pulling the chordae tendineae and mitral leaflets along.

    In the case of partial-incomplete rupture, echocardiography shows a poorly defined echo at the site of the papillary muscle, with a structure of variable size still attached to the ventricular wall but exhibiting erratic, uncoordinated movement (out of phase with the ventricular wall motion). The partially ruptured papillary muscle often displays a more or less pronounced vibrating motion. This echocardiographic finding corresponds to the tearing of a limited portion of the papillary muscle, which remains attached to the muscle body.

    This type of rupture is the most challenging to detect for several reasons: the small size of the torn portion, its proximity to the ventricular wall making it difficult to distinguish the ruptured from the healthy tissue, and the vibrating motion, which is often misinterpreted as normal (Figure 2, Movie S1).

    Bidimensional (2D) transthoracic echocardiography (TTE). Parasternal short-axis view at the papillary muscle level, in systole (A) and in diastole (B) in a patient with partial-incomplete rupture of the postero-medial papillary muscle. The red arrow indicates the torn portion of the postero-medial papillary muscle that is better recognizable in B. See Movie S1

    In the case of a partial-complete rupture, echocardiography reveals a mobile echo density of variable size, detached from the ventricular wall and exhibiting chaotic movement within the left ventricle. This finding corresponds to the partially detached head of the papillary muscle, which remains connected to the trunk by a thin strip of tissue. Although this portion of the papillary muscle shows erratic and disordered movement, it stays within the left ventricle and does not prolapse into the left atrium.

    This type of rupture presents an intermediate level of diagnostic difficulty, as the torn portion is typically large enough to be easily detected and interpreted. Occasionally, the torn segment of the papillary muscle is attached to the ventricular wall by tertiary chordae tendineae (Figures 3, 4, and 5, Movies S2 and 3).

    Bidimensional (2D) transesophageal echocardiography (TEE). The transducer is in mid/upper esophageal position with an angle of 180°. Long axis view in diastole (A) and in systole (B) in a patient with partial-complete rupture of the posteromedial papillary muscle. The red arrow indicates the ruptured portion of the postero-medial papillary muscle that is better recognizable in B. See Movie S2

    2D-TEE in the same patient of Figure 3. The transducer is in mid esophageal position with an angle of 66°. Two chamber (commissural) view in diastole (A) and in systole (B). The red arrows indicate the ruptured portion of the postero-medial papillary muscle that is better recognizable in B. The yellow arrows indicate the thin strip of tissue and the tertiary chordae tendineae that grasp the ruptured portion of the papillary muscle to the left ventricle wall. TEE: transesophageal echocardiography. See Movie S3

    Resected gross pathology specimen of the same patient of Figures 34 underwent surgical mitral valve replacement. The red arrows indicate the ruptured papillary muscle. The yellow arrows indicate the resected tertiary chordae tendineae attached directly to the ventricular wall

    In case of a complete subtotal/total (incomplete/complete) rupture, echocardiographic examination reveals a mobile echo density in the left atrium during systole, consistent with the head/heads or trunk of the ruptured papillary muscle. The size and density of the detached muscle vary widely depending on the degree of rupture and potential fibro-sclerotic changes. Sometimes the systolic mobile echo in the left atrium has an irregular shape because of tangled ruptured chordae around the muscle. Occasionally, the systolic mobile echo in the left atrium appears irregular due to tangled ruptured chordae around the muscle. This form of PMR is the easiest to diagnose, as the mobile echo, representing the papillary head, is clearly identifiable by its characteristic back-and-forth movement from the ventricle to the left atrium (Figure 6, Movie S4).

    2D-TEE in a patient with complete total rupture of the posteromedial papillary muscle. The transducer is in mid oesophageal position. Two chamber (commissural) view in diastole (left) and in systole (right). In systole the trunk of the posterior papillary muscle is seen in the left atrium. TEE: transesophageal echocardiography. See Movie S4

    If the ruptured papillary muscle partially protrudes into the mitral orifice without fully prolapsing into the left atrium, TTE may be negative, while TEE provides a definitive diagnosis (Figures 7, 8, and 9 and Movies S58).

    2D-TTE in a patient with inferior myocardial infarction. Apical four chamber view in systole. Posterior mitral leaflet prolapses into the left atrium (left); color Doppler assessment reveals severe mitral regurgitation directed towards the interatrial septum (right). TTE: transthoracic echocardiography. See Movies S5 and 6

    2D-TEE in the same patient of Figure 7. The transducer is in mid/upper esophageal position with an angle of 0°. Long axis view in systole. The red arrow indicates the head of the ruptured papillary muscle that is recognizable in the left atrium, near mitral orifice. TEE: transesophageal echocardiography. See Movie S7

    2D-TEE in the same patient of Figure 7. The transducer is in mid esophageal position with an angle of 10°. Four camber view in systole. The color Doppler assessment reveals severe mitral regurgitation directed towards the interatrial septum. A large convergence area is seen in the left ventricle (severe mitral regurgitation). TEE: transesophageal echocardiography. See Movie S8

    The impact of the different types of PMR on the mitral leaflets is highly variable (Figure 1). In cases of partial, incomplete rupture, interference with leaflet motion may be minimal, allowing overall valve kinetics to be preserved. However, even in partial rupture, interference with a large portion of the leaflet may occur, leading to severe regurgitation. In partial-complete and subtotal/total ruptures, multiple scallops of both leaflets lose their support and prolapse into the left atrium (Figures 10 and 11, Movie S9). In these cases, regurgitation is always severe.

    2D-TEE X-plane in a patient with complete total rupture of the anterior papillary muscle. The transducer is in mid esophageal position. Long axis view (left) and two chamber (commissural) view (right) in diastole. The ruptured trunk of the anterior papillary muscle is seen in the left ventricle in both views. TEE: transesophageal echocardiography. See Movie S9

    2D-TEE X-plane in the same patient of Figure 10. Long axis view (left) and two chamber (commissural) view (right) in systole. In both views part of the ruptured trunk of the anterior papillary muscle is seen in the left atrium and part remains in the ventricle. TEE: transesophageal echocardiography. See Movie S9

    To understand the relationship between the type and extent of acute PMR and the severity of mitral regurgitation, a left ventricular simulator with a porcine mitral apparatus was used. The hemodynamic effects varied considerably depending on the location and extent of the rupture. Rupture of less than two-thirds of the cords from one papillary muscle head, or rupture of the PPM head, had less significant hemodynamic effects than rupture of more than two-thirds of the cords from one head or rupture of the APM head [23].

    For an accurate transesophageal echocardiographic study of PMR anatomy, the probe positions and views recommended by guidelines are followed [24, 25].

    Longitudinal and two-chamber views with the probe in the mid-esophageal position, as well as short-axis views with the probe in transgastric and deep transgastric positions, are the most informative in our experience. In particular, for partial incomplete rupture, the most challenging form to detect, ETT and TEE short-axis views allow the identification of even minimal portions of papillary muscle showing non-coordinated movement with the ventricular wall, suggesting partial rupture (Figure 2, Movie S1).

    Mono-dimensional recording, with its high temporal resolution, reveals fluttering and vibration in the disanchored portion of the papillary muscle. Although this pattern is not an independent diagnostic criterion, it supports the diagnosis. In more advanced forms of rupture, longitudinal views enable visualization of the residual portion of the papillary muscle still attached to the left ventricular wall.

    Transthoracic examination can also be diagnostic, though some details may not be well-defined. short-axis views may lack sufficient quality to diagnose partial and incomplete ruptures. The kinetic abnormalities of the left ventricle should be carefully examined, though it is not unusual for such abnormalities to be minimal or even absent. Limited necrosis affecting only the trunk or head of the papillary muscle can result in severe mitral regurgitation without impairing the motion of the left ventricular walls. Therefore, the absence of kinetic abnormalities does not exclude acute PMR due to ischemia [2629] (Movies S13).

    Mitral regurgitation arises from the systolic eversion of scallops no longer supported by the chordae tendineae, into the left atrium. In cases of PMR with displacement of the muscle head into the left atrium, the regurgitation is also caused by the dragging of chordae and leaflet portions that follow the movement of the ruptured papillary muscle. It is important to note that a papillary muscle head can supply chordae tendineae to different scallops of the same leaflet, or even to scallops of both leaflets. This depends on the location of the rupture and the extent of muscle involvement. Consequently, the regurgitant jet does not have a consistent direction, as it can be generated by altered kinetics in both leaflets. A jet directed towards an atrial wall may be seen in cases where only one leaflet prolapses. More frequently, the posterior leaflet is involved, and the regurgitant jet is directed towards the interatrial septum (Figure 7 and Movie S6, Figure 9 and Movie S8). In cases of more extensive ruptures involving scallops from both leaflets, the jet direction is central (Figure 12, Movie S10) or predominantly towards the interatrial septum or posterior wall of the atrium.

    2D-TEE in the same patient of Figure 10 and Figure 11. Long axis view in systole. Both mitral leaflets prolapse into the left atrium (left). Color Doppler assessment reveals central severe mitral regurgitation (right). TEE: transesophageal echocardiography. See Movie S10

    In this context, three-dimensional transesophageal reconstruction may be useful, though in our opinion [30], its role is limited and primarily supports the two-dimensional transesophageal method (Figure 13, Movies S11 and 12).

    Three-dimensional transesophageal echocardiography (3D-TEE) in the patient of Figure 9 with complete total rupture of the anterior papillary muscle. Volumetric cropped image is rotated to obtain the atrial and surgical view. Still frame in systole. The red arrow indicates the head of the ruptured papillary muscle in the left atrium. The yellow arrows indicate the ruptured chordae tendineae and probably material from mitral leaflets. AML: anterior mitral leaflet; PML: posterior mitral leaflet. Movies S11 and 12

    Traditional methods for quantifying mitral regurgitation, such as those based on vena contracta or the proximal isovelocity surface area (PISA), are not applicable to this specific type of regurgitation. However, these methods are typically unnecessary, as acute mitral regurgitation in patients with PMR is almost always classified as severe based on the anatomy of the mitral valve apparatus (Figure 7 and Movie S6, Figure 9 and Movie S8, Figure 12 and Movie S10), as outlined by current guidelines [31, 32].

    Although severe, mitral regurgitation can have varying hemodynamic consequences and may be tolerated differently by patients [18].

    The echocardiographic assessment should include a comprehensive evaluation of the right ventricle, pulmonary pressures, and any coexisting pathologies, in addition to defining the mitral pathology and left ventricular function.

    Echocardiography and management of surgical and interventional therapy of acute PMR

    Acute PMR is a catastrophic event, with case reports indicating that over 80% of patients experiencing this complication develop cardiogenic shock and die within the first 24 hours. Early diagnosis and appropriate initial treatment are crucial to stabilizing the patient for subsequent procedures. Poor preoperative conditions are known to contribute to negative surgical outcomes.

    Given the high incidence of cardiogenic shock and massive pulmonary edema, mechanical circulatory support (MCS) should be used alongside medical therapy [15, 3335].

    The use of MCS, regardless of the specific device chosen for each case, should be short-term, serving as a bridge to surgery. Early surgical intervention is considered the cornerstone of treatment and the preferred option, as highlighted in current guidelines. However, questions regarding surgical options persist due to unsatisfactory outcomes. Despite advances in cardiac surgery, emergency or urgent mitral valve replacement still carries a high mortality rate. In some cases, surgery is not feasible due to unstable hemodynamics. MCS has been proposed as a means of stabilizing patients before surgery, potentially improving survival, especially when combined with aortocoronary bypass [36].

    The types of PMR that may occur clinically show different degrees of hemodynamic impairment. However, no systematic studies exist that detail the relationship between PMR, mitral regurgitation, and left ventricular function, leaving the best methods for hemodynamic stabilization and bridging to surgery largely undetermined. Moreover, no studies have evaluated how frequently and over what time period a partial rupture, which is relatively well tolerated if it does not cause severe mitral regurgitation, progresses to more severe degrees of rupture.

    Treatment decisions are often made on a case-by-case basis, considering clinical conditions and available resources. Some groups prefer to use MCS to stabilize patients before waiting for hemodynamic improvement and infarct consolidation, while others favor early surgery.

    Surgical repair is challenging due to tissue friability, and reparative surgery is often difficult. Reports suggest that transcatheter mitral clips have been used to stabilize patients or as a bridge to surgery in selected cases. However, early surgery is sometimes preferred to address severe mitral regurgitation and revascularize the patient.

    However, it should be noted that the choice of MCS depends on various factors such as the severity of the patient’s condition, the availability of resources, and the experience of the medical team. A multidisciplinary approach involving cardiologists, cardiac surgeons and critical care specialists is often necessary to plan the most appropriate therapy pathway.

    The choice of MCS is influenced by factors such as the patient’s condition, available resources, and medical team expertise. Current guidelines recommend surgery when clinical stability cannot be achieved through medical therapy, inotropic support, or mechanical assistance. Data from a multicentre cohort study show that in general surgical treatment for mechanical complications of myocardial infarction are still associated with high in-hospital mortality rates. However, long-term survival in patients surviving the immediate post-operative period is encouraging [36].

    For severely unstable patients with high surgical risk, it is debated whether mitral valve replacement is preferable to percutaneous repair, an attractive option which has shown promising results. If the PMR is partial, and adjacent tissues are less affected by ischemia, mitral valve repair may be feasible. The ACC/AHA guidelines (2013–2020) recommend mitral valve repair, if possible, particularly in cases of partial PMR where the tissue quality is suitable for repair. Factors such as surgeon experience and hemodynamic instability also play a role in determining the appropriate surgical procedure [31, 37].

    Mitral valve replacement is more commonly performed, largely due to greater surgeon experience and the established reliability and durability of the procedure. It is generally mandatory in cases of papillary muscle trunk rupture when the tissue is not suitable for repair. In such cases, a biological valve is preferred over a mechanical one when mechanical support with ventricular assist devices (VAD) or extracorporeal membrane oxygenation (ECMO) is needed, due to the high risk of thrombosis [8, 16, 3840].

    In recent years, percutaneous mitral valve repair has emerged as a promising option for high-risk surgical patients, with positive outcomes reported in reviews focusing on ischemic mitral regurgitation, including cases of PMR [4143].

    The International Registry of MitraClip in Acute Mitral Regurgitation following Acute Myocardial Infarction (IREMMI Registry) included 93 patients from 2016 to 2020 with severe post-infarction mitral regurgitation, of whom 50 had cardiogenic shock. Patients treated with percutaneous mitral clips after clinical stabilization had similar outcomes [44].

    The role of transcatheter edge-to-edge repair (TEER) was assessed in 3,797 patients with cardiogenic shock and mitral regurgitation who underwent transcatheter procedure between 2013–2021 in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry (STS/ACC/TVT registry). One-year follow-up showed that device success was associated with lower all-cause mortality and fewer incidences of heart failure [45].

    Percutaneous repair with Clip implantation has now been introduced alongside surgery for patients with PMR. TEER with Clip has proven effective in high-risk surgical cases, and isolated cases of mitral regurgitation have been successfully treated using Clip devices [4649].

    The IREMMI Registry has recently evaluated the outcomes and safety of TEER for acute mitral regurgitation after myocardial infarction. In this analysis patients treated with TEER in the acute setting due to ischemic aetiology, including complete PMR, partial muscle rupture and chordal (head) rupture, were included. In this multicentre registry, TEER was a feasible therapy in critically ill patients with PMR due to a recent myocardial infarction. TEER may have a role as salvage treatment or bridge to surgery in this population [50].

    In our experience, the application of transcatheter mitral repair with Clip/Clips is limited to cases where the regurgitation results from prolapse of part of the leaflets, without significant systolic prolapse of large amount of the papillary muscle (head or trunk) into the left atrium. In such cases (types 1 and 2 of the Moursi classification) the repair procedure targets stabilization of the prolapsed scallop/scallops, which can be effectively managed with Clip/Clips implantation.

    Echocardiographic characterization of the precise mechanisms of mitral regurgitation is crucial in planning the percutaneous procedure. For example, in our personal case involving an 85-year-old woman with acute mitral regurgitation during an inferior myocardial infarction, echocardiography revealed partial rupture of the PPM and posterior mitral leaflet prolapse. Based on echocardiographic results, the Heart Team, recommended percutaneous mitral valve repair with Clip. The targeted lesion was considered the prolapsed leaflet that was successfully clipped (Figures 14, 15, 16, 17, 18, and 19, Movies S1320).

    2D-TTE in a patient with inferior myocardial infarction. Apical long-axis view in systole. The red arrow indicates the head of posterior papillary muscle detached from its body. The echodensity of the ruptured head is increased due to fibrosclerotic evolution (left). Color Doppler assessment reveals severe mitral regurgitation directed towards the interatrial septum (right). TTE: transthoracic echocardiography. See Movies S13 and 14

    2D-TEE in the same patient of Figure 14. Mid esophageal position, 0°. Off-axis view (long axis/four camber view) in systole. The posterior leaflet prolapses into the left atrium (left). Color Doppler detects severe mitral regurgitation directed towards the interatrial septum (right). TEE: transesophageal echocardiography. See Movies S15 and 16

    2D-TEE X-plane in the same patient of Figure 14. Short axis view (left) and two-chamber view (right) with the probe in deep trans-gastric position. The plane for the two-chamber view is selected on the short axis so that the papillary muscle is imaged longitudinally (blue line). The red arrow indicates the site of papillary muscle rupture. TEE: transesophageal echocardiography. See Movie S17

    Three-dimensional transesophageal echocardiography (3D-TEE) in the patient of Figure 14. Volumetric cropped image is rotated to obtain the atrial and surgical view. Still frame in systole. The red arrow indicates the prolapsed scallop P2. See Movie S18

    Intraprocedural 2D-TEE X-plane in the same patient of Figure 14. Color Doppler in systole. Two-chamber view (left) and long-axis view (right). Positioning and release of the Clip under echocardiographic guidance. The Clip is well positioned, and the degree of residual mitral regurgitation is considered satisfactory. TEE: transesophageal echocardiography. See Movie S19

    Intraprocedural 3D-TEE in the patient of Figure 14 after the deployment of the Clip and the delivery system and of the steerable guide catheter. Volumetric cropped image is rotated to obtain the atrial and surgical view. The double orifice is well defined in diastolic frame (left). In systolic frame it is possible identify two chordae protruding in medial orifice (right). TEE: transesophageal echocardiography. See Movie S20

    Conclusions

    PMR is a serious and potentially fatal complication that can occur after a myocardial infarction. Early and accurate echocardiographic diagnosis is essential for identifying the anatomical features of the rupture and for evaluating the severity of mitral regurgitation. Tailored management is critical, with treatment strategies varying according to the echocardiographic findings and the patient’s clinical condition. While some patients may require surgical intervention to repair or replace the mitral valve, less invasive percutaneous interventions may be suitable for carefully selected patients, as determined by echocardiographic assessment.

    The involvement of a multidisciplinary heart team, including cardiologists, cardiac surgeons and other specialists, is crucial in formulating the most appropriate treatment strategy.

    Despite advancements in both the diagnosis and management of PMR, further studies are needed to refine treatment protocol and guide optimal therapeutic approaches.

    Abbreviations

    APM:

    anterolateral papillary muscle

    LCX:

    left circumflex artery

    MCS:

    mechanical circulatory support

    PMR:

    papillary muscle rupture

    PPM:

    posteromedial papillary muscle

    TEE:

    transesophageal echocardiography

    TEER:

    transcatheter edge-to-edge repair

    TTE:

    transthoracic echocardiography

    Supplementary materials

    The supplementary material for this article is available at: https://www.explorationpub.com/uploads/Article/file/101242_sup_1.pdf.

    Declarations

    Author contributions

    PGP: Conceptualization, Writing—original draft, Validation, Supervision, Writing—review & editing. IP: Conceptualization, Writing—original draft. AM: Conceptualization, Writing—original draft. AT: Writing—review & editing. FN: Validation, Writing—review & editing. All authors read and approved the submitted version.

    Conflicts of interest

    The authors declare that they have no conflicts of interest.

    Ethical approval

    Ethics approval is not required for this study according to our local Ethics Committee since it is routine activity at the echocardiography lab.

    Consent to participate

    Informed consent to participate in the study was obtained from relevant participants.

    Consent to publication

    Not applicable.

    Availability of data and materials

    Requests for accessing the data sets should be directed to Paolo G. Pino, aries52@libero.it.

    Funding

    Not applicable.

    Copyright

    © The Author(s) 2025.

    Publisher’s note

    Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.

    References

    Figueras J, Alcalde O, Barrabés JA, Serra V, Alguersuari J, Cortadellas J, et al. Changes in hospital mortality rates in 425 patients with acute ST-elevation myocardial infarction and cardiac rupture over a 30-year period. Circulation. 2008;118:27839. [DOI] [PubMed]
    Elbadawi A, Elgendy IY, Mahmoud K, Barakat AF, Mentias A, Mohamed AH, et al. Temporal Trends and Outcomes of Mechanical Complications in Patients With Acute Myocardial Infarction. JACC Cardiovasc Interv. 2019;12:182536. [DOI] [PubMed]
    Puerto E, Viana-Tejedor A, Martínez-Sellés M, Domínguez-Pérez L, Moreno G, Martín-Asenjo R, et al. Temporal Trends in Mechanical Complications of Acute Myocardial Infarction in the Elderly. J Am Coll Cardiol. 2018;72:95966. [DOI] [PubMed]
    Bhardwaj B, Sidhu G, Balla S, Kumar V, Kumar A, Aggarwal K, et al. Outcomes and Hospital Utilization in Patients With Papillary Muscle Rupture Associated With Acute Myocardial Infarction. Am J Cardiol. 2020;125:10205. [DOI] [PubMed]
    Moreno PR, Fuster V. JACC Focus Seminar on Mechanical Complications of Acute Myocardial Infarction. J Am Coll Cardiol. 2024;83:17758. [DOI] [PubMed]
    Estévez-Loureiro R, Lorusso R, Taramasso M, Torregrossa G, Kini A, Moreno PR. Management of Severe Mitral Regurgitation in Patients With Acute Myocardial Infarction: JACC Focus Seminar 2/5. J Am Coll Cardiol. 2024;83:1799817. [DOI] [PubMed]
    Nishimura RA, Schaff HV, Shub C, Gersh BJ, Edwards WD, Tajik AJ. Papillary muscle rupture complicating acute myocardial infarction: analysis of 17 patients. Am J Cardiol. 1983;51:3737. [DOI] [PubMed]
    Damluji AA, van Diepen S, Katz JN, Menon V, Tamis-Holland JE, Bakitas M, et al.; American Heart Association Council on Clinical Cardiology; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Surgery and Anesthesia; and Council on Cardiovascular and Stroke Nursing. Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association. Circulation. 2021;144:e1635. [DOI] [PubMed] [PMC]
    Estes EH Jr, Dalton FM, Entman ML, Dixon HB 2nd, Hackel DB. The anatomy and blood supply of the papillary muscles of the left ventricle. Am Heart J. 1966;71:35662. [DOI] [PubMed]
    Ranganathan N, Burch GE. Gross morphology and arterial supply of the papillary muscles of the left ventricle of man. Am Heart J. 1969;77:50616. [DOI] [PubMed]
    Rajiah P, Fulton NL, Bolen M. Magnetic resonance imaging of the papillary muscles of the left ventricle: normal anatomy, variants, and abnormalities. Insights Imaging. 2019;10:83. [DOI] [PubMed] [PMC]
    Bouma W, Wijdh-den Hamer IJ, Koene BM, Kuijpers M, Natour E, Erasmus ME, et al. Long-term survival after mitral valve surgery for post-myocardial infarction papillary muscle rupture. J Cardiothorac Surg. 2015;10:11. [DOI] [PubMed] [PMC]
    Barbour DJ, Roberts WC. Rupture of a left ventricular papillary muscle during acute myocardial infarction: analysis of 22 necropsy patients. J Am Coll Cardiol. 1986;8:55865. [DOI] [PubMed]
    Wei JY, Hutchins GM, Bulkley BH. Papillary muscle rupture in fatal acute myocardial infarction: a potentially treatable form of cardiogenic shock. Ann Intern Med. 1979;90:14952. [DOI] [PubMed]
    Pahuja M, Ranka S, Chauhan K, Patel A, Chehab O, Elmoghrabi A, et al. Rupture of Papillary Muscle and Chordae Tendinae Complicating STEMI: A Call for Action. ASAIO J. 2021;67:90716. [DOI] [PubMed]
    Bouma W, Wijdh-den Hamer IJ, Klinkenberg TJ, Kuijpers M, Bijleveld A, van der Horst IC, et al. Mitral valve repair for post-myocardial infarction papillary muscle rupture. Eur J Cardiothorac Surg. 2013;44:10639. [DOI] [PubMed] [PMC]
    Sultan I, Aranda-Michel E, Gleason TG, Navid F, Kilic A. Mitral valve surgery for acute papillary muscle rupture. J Card Surg. 2018;33:4848. [DOI] [PubMed]
    Shuvy M, Maisano F, Strauss BH. Transcatheter Mitral Edge-to-Edge Repair for Treatment of Acute Mitral Regurgitation. Can J Cardiol. 2023;39:13829. [DOI] [PubMed]
    Mintz GS, Victor MF, Kotler MN, Parry WR, Segal BL. Two-dimensional echocardiographic identification of surgically correctable complications of acute myocardial infarction. Circulation. 1981;64:916. [DOI] [PubMed]
    Erbel R, Schweizer P, Bardos P, Meyer J. Two-dimensional echocardiographic diagnosis of papillary muscle rupture. Chest. 1981;79:5958. [DOI] [PubMed]
    Come PC, Riley MF, Weintraub R, Morgan JP, Nakao S. Echocardiographic detection of complete and partial papillary muscle rupture during acute myocardial infarction. Am J Cardiol. 1985;56:7879. [DOI] [PubMed]
    Moursi MH, Bhatnagar SK, Vilacosta I, San Roman JA, Espinal MA, Nanda NC. Transesophageal echocardiographic assessment of papillary muscle rupture. Circulation. 1996;94:10039. [DOI] [PubMed]
    Marin-Cuartas M, Zhu Y, Imbrie-Moore AM, Park MH, Wilkerson RJ, Leipzig M, et al. Biomechanical engineering analysis of an acute papillary muscle rupture disease model using an innovative 3D-printed left heart simulator. Interact Cardiovasc Thorac Surg. 2022;34:82230. [DOI] [PubMed] [PMC]
    Hahn RT, Abraham T, Adams MS, Bruce CJ, Glas KE, Lang RM, et al. Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr. 2013;26:92164. [DOI] [PubMed]
    Flachskampf FA, Wouters PF, Edvardsen T, Evangelista A, Habib G, Hoffman P, et al.; European Association of Cardiovascular Imaging Document reviewers: Erwan Donal and Fausto Rigo. Recommendations for transoesophageal echocardiography: EACVI update 2014. Eur Heart J Cardiovasc Imaging. 2014;15:35365. [DOI] [PubMed]
    Sawhney V, Murugan S, Iqbal F, Muthumala A. Rupture of mitral valve papillary muscle: a rare complication following myocardial infarction. BMJ Case Rep. 2020;13:e232626. [DOI] [PubMed] [PMC]
    Kameyama A, Imamura H, Kamijo H, Takeshige K, Mochizuki K, Nitta K. Diagnostic Pitfalls in Papillary Muscle Rupture-Associated Acute Mitral Regurgitation after Acute Myocardial Infarction. Case Rep Crit Care. 2021;2021:1396194. [DOI] [PubMed] [PMC]
    Kono T, Takagi K, Negoto S, Tayama E. Anterior Papillary Muscle Rupture due to Acute Myocardial Microinfarction of the Small High Lateral Branch. Case Rep Cardiol. 2022;2022:7149724. [DOI] [PubMed] [PMC]
    Hisata Y, Tanigawa A, Yamada T. Partial Anterior Papillary Muscle Rupture Due to Diagonal Branch Occlusion. Circ J. 2022;86:2042. [DOI] [PubMed]
    Pino PG, Madeo A, Lucà F, Ceravolo R, di Fusco SA, Benedetto FA, et al. Clinical Utility of Three-Dimensional Echocardiography in the Evaluation of Mitral Valve Disease: Tips and Tricks. J Clin Med. 2023;12:2522. [DOI] [PubMed] [PMC]
    Writing Committee Members; Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;77:e25197. [DOI] [PubMed]
    Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al.; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43:561632. [DOI] [PubMed]
    Schrage B, Becher PM, Goßling A, Savarese G, Dabboura S, Yan I, et al. Temporal trends in incidence, causes, use of mechanical circulatory support and mortality in cardiogenic shock. ESC Heart Fail. 2021;8:1295303. [DOI] [PubMed] [PMC]
    Ekanem E, Gattani R, Bakhshi H, Tehrani B, Batchelor W. Combined Venoarterial ECMO and Impella-CP Circulatory Support for Cardiogenic Shock Due to Papillary Muscle Rupture. JACC Case Rep. 2020;2:216972. [DOI] [PubMed] [PMC]
    DiVita M, Visveswaran GK, Makam K, Naji P, Cohen M, Kapoor S, et al. Emergent TandemHeart-ECMO for acute severe mitral regurgitation with cardiogenic shock and hypoxaemia: a case series. Eur Heart J Case Rep. 2020;4:16. [DOI] [PubMed] [PMC]
    Matteucci M, Ronco D, Kowalewski M, Massimi G, De Bonis M, Formica F, et al. Long-term survival after surgical treatment for post-infarction mechanical complications: results from the Caution study. Eur Heart J Qual Care Clin Outcomes. 2024:qcae010. [DOI] [PubMed]
    O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al.; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e362425. [DOI] [PubMed]
    Hamid UI, Aksoy R, Sardari Nia P. Mitral valve repair in papillary muscle rupture. Ann Cardiothorac Surg. 2022;11:2819. [DOI] [PubMed] [PMC]
    Massimi G, Matteucci M, Kowalewski M, Ronco D, Jiritano F, Beghi C, et al. Surgical treatment of post-infarction papillary muscle rupture: systematic review and meta-analysis. Ann Cardiothorac Surg. 2022;11:25260. [DOI] [PubMed] [PMC]
    Massimi G, Ronco D, De Bonis M, Kowalewski M, Formica F, Russo CF, et al. Surgical treatment for post-infarction papillary muscle rupture: a multicentre study. Eur J Cardiothorac Surg. 2022;61:46976. [DOI] [PubMed]
    Gomez-Polo JC, Buzzatti N, Denti P, Gatto P, Scandroglio M, Aiello S, et al. Post-infarct mitral insufficiency: when to resort to reparative surgery, when to the mitral clip. Eur Heart J Suppl. 2022;24:I10410. [DOI] [PubMed] [PMC]
    Estévez-Loureiro R, Tavares Da Silva M, Baz-Alonso JA, Caneiro-Queija B, Barreiro-Pérez M, Calvo-Iglesias F, et al. Percutaneous mitral valve repair in patients developing severe mitral regurgitation early after an acute myocardial infarction: A review. Front Cardiovasc Med. 2022;9:987122. [DOI] [PubMed] [PMC]
    Haberman D, Estévez-Loureiro R, Benito-Gonzalez T, Denti P, Arzamendi D, Adamo M, et al. Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction. Eur Heart J. 2022;43:64150. [DOI] [PubMed]
    Estévez-Loureiro R, Shuvy M, Taramasso M, Benito-Gonzalez T, Denti P, Arzamendi D, et al. Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry). Catheter Cardiovasc Interv. 2021;97:125967. [DOI] [PubMed]
    Simard T, Vemulapalli S, Jung RG, Vekstein A, Stebbins A, Holmes DR, et al. Transcatheter Edge-to-Edge Mitral Valve Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock. J Am Coll Cardiol. 2022;80:207284. [DOI] [PubMed]
    Bilge M, Alemdar R, Yasar AS. Successful percutaneous mitral valve repair with the MitraClip system of acute mitral regurgitation due to papillary muscle rupture as complication of acute myocardial infarction. Catheter Cardiovasc Interv. 2014;83:E13740. [DOI] [PubMed]
    Valle JA, Miyasaka RL, Carroll JD. Acute Mitral Regurgitation Secondary to Papillary Muscle Tear: Is Transcatheter Edge-to-Edge Mitral Valve Repair a New Paradigm? Circ Cardiovasc Interv. 2017;10:e005050. [DOI] [PubMed]
    Yasin M, Nanjundappa A, Annie FH, Tager A, Farooq A, Bhagat A, et al. Use of MitraClip for Postmyocardial Infarction Mitral Regurgitation Secondary to Papillary Muscle Dysfunction. Cureus. 2018;10:e3065. [DOI] [PubMed] [PMC]
    Huang H, Wang Z, Zang X, Zhao J. Totally endoscopic minimally invasive mitral valvuloplasty with a beating heart for treatment of papillary muscle rupture. JTCVS Tech. 2023;21:98101. [DOI] [PubMed] [PMC]
    Haberman D, Estévez-Loureiro R, Czarnecki A, Denti P, Villablanca P, Spargias K, et al. Transcatheter edge-to-edge repair in papillary muscle injury complicating acute myocardial infarction. ESC Heart Fail. 2024;11:121827. [DOI] [PubMed] [PMC]